U.S. RESEARCH ROUNDUP- Amphastar Pharmaceuticals, Bioxcel Therapeutics, Pure Storage

Amphastar Pharmaceuticals,

31/12/2021 07:09

Dec 31 (Reuters) - Wall Street securities analysts revised their ratings and price targets
on several U.S.-listed companies, including Amphastar Pharmaceuticals, Bioxcel Therapeutics and
Pure Storage on Friday. 
    
  HIGHLIGHTS        
     * Amphastar Pharmaceuticals Inc  AMPH.O : Northland Capital raises PT to $29 from $24
     * Bioxcel Therapeutics Inc  BTAI.O : Jefferies cuts target price to $73 from $86
     * Pure Storage Inc  PSTG.N : Susquehanna raises target price to $40 from $36
                
Following is a summary of research actions on U.S. companies reported by Reuters on Friday.
Stock entries are in alphabetical order.   
     * Amphastar Pharmaceuticals Inc  AMPH.O : Northland Capital raises PT to $29 from $24
     * Bioxcel Therapeutics Inc  BTAI.O : Jefferies cuts target price to $73 from $86
     * Corcept Therapeutics Inc  CORT.O : Jefferies raises target price to $22 from $19
     * Fuelcell Energy Inc  FCEL.O : Canaccord Genuity cuts target price to $5.5 from $7
     * Pluristem Therapeutics Inc  PSTI.O : Alliance Global Partners cuts PT to $9.5 from $12.5
     * Pure Storage Inc  PSTG.N : Susquehanna raises target price to $40 from $36
 
 (Compiled by Bengaluru Newsroom)
 ((Diaries@thomsonreuters.com))